ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,854.10
0.83%
S&P ASX All Technology
3,468.50
0.54%
Brent Oil
70.715
-0.07%
US Dollar vs AUD
1.58019
0.03%
Bitcoin
83,095.60
0.66%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pulmonx Corporation (LUNG) Share Price

Pulmonx Corporation

Pulmonx Corporation (LUNG)

NASDAQ
7.52
0.47
(6.67%)
Closed 17 March 7:00AM
Delayed by 15 minutes
7.52
0.00
(0.00%)
After Hours: 8:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
7.52
Bid
6.89
Offer
20.92
Volume
192,854
7.04 Day's Range 7.53
5.46 52 Week Range 10.01
Market Cap
299.269M
Previous Close
7.05
Open
7.04
Last Trade
1
@
7.89
Last Trade Time
Financial Volume
US$ 1,413,977
VWAP
7.3319
Average Volume (3m)
314,365
Shares Outstanding
39,796,420
Dividend Yield
-
PE Ratio
-4.92
Earnings Per Share (EPS)
-1.53
Revenue
68.68M
Net Profit
-60.84M

About Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.pulmonx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Pulmonx Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUNG. The last closing price for Pulmonx was US$7.05. Over the last year, Pulmonx shares have traded in a share price range of US$ 5.46 to US$ 10.01.

Pulmonx currently has 39,796,420 shares in issue. The market capitalisation of Pulmonx is US$280.56 million. Pulmonx has a price to earnings ratio (PE ratio) of -4.92.

Ask ADVFN Intelligence (AI)

LUNG Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
LUNG (6.67%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
LUNG (6.67%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
LUNG (6.67%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
LUNG (6.67%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 March 2025
LUNG (6.67%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
26 February 2025
LUNG (6.67%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
26 February 2025
LUNG (6.67%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 February 2025
LUNG (6.67%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
21 February 2025
LUNG (6.67%)

Form 8-K - Current report
Edgar (US Regulatory)
20 February 2025
LUNG (6.67%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.131.759133964827.397.86.972239277.28280037CS
40.081.07526881727.449.376.4955088338.35139315CS
121.7129.43201376945.819.375.573143657.53424087CS
26-0.85-10.15531660698.379.375.572653237.22117535CS
52-1.32-14.93212669688.8410.015.463486087.52612972CS
156-14.3-65.536205316221.8228.34.0738847011.35449993CS
260-30.48-80.21052631583869.47794.0737477320.12440562CS

LUNG - Frequently Asked Questions (FAQ)

What is the current Pulmonx share price?
The current share price of Pulmonx is US$ 7.52
How many Pulmonx shares are in issue?
Pulmonx has 39,796,420 shares in issue
What is the market cap of Pulmonx?
The market capitalisation of Pulmonx is USD 280.56M
What is the 1 year trading range for Pulmonx share price?
Pulmonx has traded in the range of US$ 5.46 to US$ 10.01 during the past year
What is the PE ratio of Pulmonx?
The price to earnings ratio of Pulmonx is -4.92
What is the cash to sales ratio of Pulmonx?
The cash to sales ratio of Pulmonx is 4.36
What is the reporting currency for Pulmonx?
Pulmonx reports financial results in USD
What is the latest annual turnover for Pulmonx?
The latest annual turnover of Pulmonx is USD 68.68M
What is the latest annual profit for Pulmonx?
The latest annual profit of Pulmonx is USD -60.84M
What is the registered address of Pulmonx?
The registered address for Pulmonx is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Pulmonx website address?
The website address for Pulmonx is www.pulmonx.com
Which industry sector does Pulmonx operate in?
Pulmonx operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDUSRadius Recycling Inc
US$ 27.902
(104.26%)
8.53M
BONBon Natural Life Ltd
US$ 1.40
(90.29%)
84M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255.00
(39.80%)
222
AAOIApplied Optoelectronics Inc
US$ 22.105
(39.29%)
17.01M
GLSTUGlobal Star Acquisition Inc
US$ 2.00
(-69.23%)
421
CURRCurrenc Group Inc
US$ 2.03
(-41.33%)
1.42M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
WKSPWorksport Ltd
US$ 0.36205
(-35.45%)
4.96M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
NVDANVIDIA Corporation
US$ 121.67
(5.27%)
277.56M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.225
(7.64%)
160.21M

Discussion

View Full Feed
Tom turtles Tom turtles 3 minutes ago
Bitcoin going bizerk next week ....CORZ !
CORZ
pgsd pgsd 6 minutes ago
Dr. Thomas Ichim
@exosome
Why are "lysate" vaccines like those developed by $NWBO better than peptide vaccines? Because lysate has all the antigens. See this paper showing immunity to multiple cancer antigens after melanoma lysate.

https://pmc.ncbi.nlm.nih.gov/articles
NWBO
janice shell janice shell 7 minutes ago
No. I have never seen anyone like Trump. He is insane. And seriously, is NO ONE trying to stop him? Somebody should be. An associate. A family member. Flag officers who feel a sense of duty. A combination of all of them.

The associates and family members ought to realize as well that
arizona1 arizona1 8 minutes ago
He's trying to break our brains. Is it working?
RealDutch RealDutch 11 minutes ago
Just SIRI, for now.
SIRI
MaterialMind MaterialMind 13 minutes ago
The initial cash grants will be paid on SIRI? I think that was the latest I heard, but my memory is not good. Or is it an average over SIRI / AERO / ... ?
SIRI
janice shell janice shell 14 minutes ago
He is insane. He needs to be removed from office.

https://www.youtube.com/watch?v=d-Wf3JQNjEU
arizona1 arizona1 15 minutes ago
Have you ever witnessed a human being who needs revenge on his enemies the same way people need air? We need the 25th amendment NOW!!!!
Pacha78 Pacha78 15 minutes ago
I get your theory but MCIC has had very strong stable buying over the past few month.  This isn't an OTC pump and dump over a few days
MCIC
janice shell janice shell 18 minutes ago
You're right. If he has so many great ideas about how to cure serious diseases, what about his own?

And speaking of crazy, this is bizarre. Trump is insane. And he's getting crazier by the day.

https://x.com/MeidasTouch/status/1901507835487461511
arizona1 arizona1 20 minutes ago
Yeah, well, if all his vitamin remedies are so good for him, why does he still talk like he's under water? Surely Vitamin A and leeches should be able to cure him.

Robert F. Kennedy Jr. has a raspy, strained voice due to a neurological condition called spasmodic dysphonia, which caus
RealDutch RealDutch 22 minutes ago
Only SIRI has been updated. The rest will follow shortly.

SIRI, AERO and Rice are the three big verticals.
Together they will probably account for 50%+ of total revenue, in the long run.
And we will have another 40 or so smaller verticals.

Rice is big beca
SIRI
janice shell janice shell 27 minutes ago
Seems the non-effectiveness has been verified. But of course RFK Jr can always raise the issue again. Treating measles with Vitamin A isn't new, either.
getmenews getmenews 32 minutes ago
Breaking news, XRP drops to 1.51 Over-Night?
XRPUSD
rooster rooster 37 minutes ago
Lame
arizona1 arizona1 38 minutes ago
There were and are some people with multiple sclerosis who believe bee stings treat their disease.

My first husband had MS. I can verify bee stings didn't do diddly squat. I remember once, he was chopping wood and axed into a beehive. He and my daughter got pelted with bees. She m
MaterialMind MaterialMind 39 minutes ago
were all of your verticals updated or just SIRI?
As I understand it, the other verticals will be adjusted later. For now I've only checked SIRI.
It's the one I care most about tbh. I really like the gold business model.
SIRI
MaterialMind MaterialMind 40 minutes ago
Thanks, that sorts out that last question mark!
I've gotten confirmation that my tokens will be adjusted, it was as I suspected.
The team has a lot on their plates, no wonder some details have to be corrected.
Getting it sorted out before things are set in motion is the importan
ITUP
karlacorn3 karlacorn3 42 minutes ago
Material, were all of your verticals updated or just SIRI?
K
SIRI
Riley4 Riley4 43 minutes ago
What?
NWBO
janice shell janice shell 46 minutes ago
Ahhh, bee venom is another substance of interest. There were and are some people with multiple sclerosis who believe bee stings treat their disease. And maybe other autoimmune diseases. For a while, it seems to have been kind of a cult thing.

However, I just looked it up Seems the NIH
lodas lodas 54 minutes ago
as usual, you have nothing to add to your expectations for recovery except some indiscript numbers that are meaningless without a link to the source....so, I won't bother with those that did not read the official documents.... here is an official statement made by the source, WMI..... your equity sh
COOP
ducci1 ducci1 55 minutes ago
Charts: Objective for Mon----SPX Retake 15 min Red Line & R1 5667 for Channel B/O ??? ( 50% Fib 5664 Previous Support Now Resistance )
SPY
knrorrel knrorrel 57 minutes ago
QNCCF back at #1 in Canada Chat

https://ceo.ca/content/companies?exchange=all&sort_by=trending§or=All


QNCCF

Your Recent History

NASDAQ
LUNG
Pulmonx
COIN
GOLDEUR
COIN
EVTNBTC
Exva Token
EU
IPR
Impresa SGPS
NASDAQ
FBKUX
Agf Floating Rate Income...
NASDAQ
PONY
Pony AI
USOTC
PQEFF
Petroteq Energy (CE)
LSE
0K2D
Techstep Asa
NASDAQ
HAYN
Haynes
TG
V1ZB
Cofiroute
TG
XNPD
CNP Assurances
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads